Cogo Attention Training Programme is a digital solution provided by Neeuro. Paired with the Neero SenzeBand 2, it encompasses several categories of digital health solutions including Digital Therapeutics (DTx) and DIY Care.
Resources that are helpful in understanding about the Cogo Attention Training Programme includes: Exploring the Potential of Digital Therapeutics (WEBINAR) and A Buyer’s Guide to Digital Therapeutics
Digital Therapeutics​ - Cogo Attention Training Programme
Cogo is a patented, scientifically validated digital therapeutic and attention training programme based on Brain-Computer Interface (BCI) technology, suitable for 6 to 12 years old children who exhibit inattentive symptoms. It is jointly developed by A*STAR’s Institute for Infocomm Research (I2R), Institute of Mental Health, and Duke-NUS Medical School in Singapore through a decade of research and clinical trials.
Paired with Neeuro SenzeBand 2, the Cogo Attention Training Programme is a 24-session programme. Practitioners can supervise the child's progress either at the clinic or through an online dashboard where the session achievements are tracked. Parents can also receive a progress report as the child completes different sessions. The programme can be completed within 2 to 3 months, at 2 or 3 sessions per week, 30 minutes per session.
Resources that are helpful in understanding about the Cogo Attention Training Programme includes: Exploring the Potential of Digital Therapeutics (WEBINAR) and A Buyer’s Guide to Digital Therapeutics
Neeuro SenzeBand 2​
The Neeuro SenzeBand 2 is a non-invasive device for capturing EEG (brainwaves) signals. It consists of 7 dry electrodes with five located on the prefrontal cortex and two on the sides. Together with Neeuro’s machine learning algorithms, it interprets these EEG signals into various mental states, like attention, relaxation, mental workload, fatigue, stress, and many more. This provides insightful biofeedback for measurements used in real-time to drive interventions for various brain health challenges.